Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028227

Options or other derivatives

  • Director returned 182,484 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Shetty Ajit · Director

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2025-03-31 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −2,500 0 D
2025-03-31 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −2,500 0 D
2025-03-31 Returned to the company : show line 3 in the form tock Option (Right to Buy) −8,333 0 D
2025-03-31 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −8,333 0 D
2025-03-31 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −18,351 0 D
2025-03-31 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −72,156 0 D
2025-03-31 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −70,311 0 D
Loading xslF345X05/ownership.xml…